IBDEI027 ; ; 06-AUG-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 06, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,2488,1,3,0)
 ;;=3^SCREENING FOR MALARIA
 ;;^UTILITY(U,$J,358.3,2488,1,4,0)
 ;;=4^V75.1
 ;;^UTILITY(U,$J,358.3,2488,2)
 ;;=^295642
 ;;^UTILITY(U,$J,358.3,2489,0)
 ;;=V75.2^^27^188^15
 ;;^UTILITY(U,$J,358.3,2489,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2489,1,3,0)
 ;;=3^SCREEN FOR LEISHMANIASIS
 ;;^UTILITY(U,$J,358.3,2489,1,4,0)
 ;;=4^V75.2
 ;;^UTILITY(U,$J,358.3,2489,2)
 ;;=^295643
 ;;^UTILITY(U,$J,358.3,2490,0)
 ;;=V75.3^^27^188^53
 ;;^UTILITY(U,$J,358.3,2490,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2490,1,3,0)
 ;;=3^SCREEN-TRYPANOSOMIASIS
 ;;^UTILITY(U,$J,358.3,2490,1,4,0)
 ;;=4^V75.3
 ;;^UTILITY(U,$J,358.3,2490,2)
 ;;=^295644
 ;;^UTILITY(U,$J,358.3,2491,0)
 ;;=V75.4^^27^188^41
 ;;^UTILITY(U,$J,358.3,2491,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2491,1,3,0)
 ;;=3^SCREEN-MYCOTIC INFECT
 ;;^UTILITY(U,$J,358.3,2491,1,4,0)
 ;;=4^V75.4
 ;;^UTILITY(U,$J,358.3,2491,2)
 ;;=^295645
 ;;^UTILITY(U,$J,358.3,2492,0)
 ;;=V75.5^^27^188^49
 ;;^UTILITY(U,$J,358.3,2492,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2492,1,3,0)
 ;;=3^SCREEN-SCHISTOSOMIASIS
 ;;^UTILITY(U,$J,358.3,2492,1,4,0)
 ;;=4^V75.5
 ;;^UTILITY(U,$J,358.3,2492,2)
 ;;=^295646
 ;;^UTILITY(U,$J,358.3,2493,0)
 ;;=V75.6^^27^188^10
 ;;^UTILITY(U,$J,358.3,2493,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2493,1,3,0)
 ;;=3^SCREEN FOR FILARIASIS
 ;;^UTILITY(U,$J,358.3,2493,1,4,0)
 ;;=4^V75.6
 ;;^UTILITY(U,$J,358.3,2493,2)
 ;;=^295647
 ;;^UTILITY(U,$J,358.3,2494,0)
 ;;=V75.7^^27^188^13
 ;;^UTILITY(U,$J,358.3,2494,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2494,1,3,0)
 ;;=3^SCREEN FOR HELMINTHIASIS
 ;;^UTILITY(U,$J,358.3,2494,1,4,0)
 ;;=4^V75.7
 ;;^UTILITY(U,$J,358.3,2494,2)
 ;;=^295648
 ;;^UTILITY(U,$J,358.3,2495,0)
 ;;=V75.8^^27^188^43
 ;;^UTILITY(U,$J,358.3,2495,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2495,1,3,0)
 ;;=3^SCREEN-PARASITIC DIS NEC
 ;;^UTILITY(U,$J,358.3,2495,1,4,0)
 ;;=4^V75.8
 ;;^UTILITY(U,$J,358.3,2495,2)
 ;;=^295649
 ;;^UTILITY(U,$J,358.3,2496,0)
 ;;=V76.0^^27^188^24
 ;;^UTILITY(U,$J,358.3,2496,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2496,1,3,0)
 ;;=3^SCREEN MAL NEOP-RESP ORG
 ;;^UTILITY(U,$J,358.3,2496,1,4,0)
 ;;=4^V76.0
 ;;^UTILITY(U,$J,358.3,2496,2)
 ;;=^295651
 ;;^UTILITY(U,$J,358.3,2497,0)
 ;;=V76.10^^27^188^26
 ;;^UTILITY(U,$J,358.3,2497,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2497,1,3,0)
 ;;=3^SCREEN MAL NEOPL, BREAST,UNSP
 ;;^UTILITY(U,$J,358.3,2497,1,4,0)
 ;;=4^V76.10
 ;;^UTILITY(U,$J,358.3,2497,2)
 ;;=^317968
 ;;^UTILITY(U,$J,358.3,2498,0)
 ;;=V76.11^^27^188^27
 ;;^UTILITY(U,$J,358.3,2498,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2498,1,3,0)
 ;;=3^SCREEN MAMMO HIGH-RISK PT
 ;;^UTILITY(U,$J,358.3,2498,1,4,0)
 ;;=4^V76.11
 ;;^UTILITY(U,$J,358.3,2498,2)
 ;;=^317969
 ;;^UTILITY(U,$J,358.3,2499,0)
 ;;=V76.12^^27^188^8
 ;;^UTILITY(U,$J,358.3,2499,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2499,1,3,0)
 ;;=3^OTHER SCREEN MAMMO FOR MAL NEO
 ;;^UTILITY(U,$J,358.3,2499,1,4,0)
 ;;=4^V76.12
 ;;^UTILITY(U,$J,358.3,2499,2)
 ;;=^317970
 ;;^UTILITY(U,$J,358.3,2500,0)
 ;;=V76.19^^27^188^7
 ;;^UTILITY(U,$J,358.3,2500,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2500,1,3,0)
 ;;=3^OTHER SCREEN BREAST EXAM
 ;;^UTILITY(U,$J,358.3,2500,1,4,0)
 ;;=4^V76.19
 ;;^UTILITY(U,$J,358.3,2500,2)
 ;;=^295652
 ;;^UTILITY(U,$J,358.3,2501,0)
 ;;=V76.2^^27^188^21
 ;;^UTILITY(U,$J,358.3,2501,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2501,1,3,0)
 ;;=3^SCREEN MAL NEOP-CERVIX
 ;;^UTILITY(U,$J,358.3,2501,1,4,0)
 ;;=4^V76.2
 ;;^UTILITY(U,$J,358.3,2501,2)
 ;;=^295653
 ;;^UTILITY(U,$J,358.3,2502,0)
 ;;=V76.3^^27^188^20
 ;;^UTILITY(U,$J,358.3,2502,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2502,1,3,0)
 ;;=3^SCREEN MAL NEOP-BLADDER
 ;;^UTILITY(U,$J,358.3,2502,1,4,0)
 ;;=4^V76.3
 ;;^UTILITY(U,$J,358.3,2502,2)
 ;;=^295654
 ;;^UTILITY(U,$J,358.3,2503,0)
 ;;=V76.41^^27^188^23
 ;;^UTILITY(U,$J,358.3,2503,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2503,1,3,0)
 ;;=3^SCREEN MAL NEOP-RECTUM
 ;;^UTILITY(U,$J,358.3,2503,1,4,0)
 ;;=4^V76.41
 ;;^UTILITY(U,$J,358.3,2503,2)
 ;;=^295655
 ;;^UTILITY(U,$J,358.3,2504,0)
 ;;=V76.42^^27^188^22
 ;;^UTILITY(U,$J,358.3,2504,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2504,1,3,0)
 ;;=3^SCREEN MAL NEOP-ORAL CAV
 ;;^UTILITY(U,$J,358.3,2504,1,4,0)
 ;;=4^V76.42
 ;;^UTILITY(U,$J,358.3,2504,2)
 ;;=^295656
 ;;^UTILITY(U,$J,358.3,2505,0)
 ;;=V76.43^^27^188^25
 ;;^UTILITY(U,$J,358.3,2505,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2505,1,3,0)
 ;;=3^SCREEN MAL NEOP-SKIN
 ;;^UTILITY(U,$J,358.3,2505,1,4,0)
 ;;=4^V76.43
 ;;^UTILITY(U,$J,358.3,2505,2)
 ;;=^295657
 ;;^UTILITY(U,$J,358.3,2506,0)
 ;;=V76.44^^27^188^73
 ;;^UTILITY(U,$J,358.3,2506,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2506,1,3,0)
 ;;=3^SP SCR-MALIG NEOP PROSTATE
 ;;^UTILITY(U,$J,358.3,2506,1,4,0)
 ;;=4^V76.44
 ;;^UTILITY(U,$J,358.3,2506,2)
 ;;=^321548
 ;;^UTILITY(U,$J,358.3,2507,0)
 ;;=V76.45^^27^188^74
 ;;^UTILITY(U,$J,358.3,2507,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2507,1,3,0)
 ;;=3^SP SCR-MALIG NEOP TESTIS
 ;;^UTILITY(U,$J,358.3,2507,1,4,0)
 ;;=4^V76.45
 ;;^UTILITY(U,$J,358.3,2507,2)
 ;;=^321549
 ;;^UTILITY(U,$J,358.3,2508,0)
 ;;=V76.46^^27^188^82
 ;;^UTILITY(U,$J,358.3,2508,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2508,1,3,0)
 ;;=3^SPEC SCRN MALIG NEOPLASM,OVARY
 ;;^UTILITY(U,$J,358.3,2508,1,4,0)
 ;;=4^V76.46
 ;;^UTILITY(U,$J,358.3,2508,2)
 ;;=^322084
 ;;^UTILITY(U,$J,358.3,2509,0)
 ;;=V76.47^^27^188^81
 ;;^UTILITY(U,$J,358.3,2509,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2509,1,3,0)
 ;;=3^SPEC SCRN MALIG NEOPLAS,VAGINA
 ;;^UTILITY(U,$J,358.3,2509,1,4,0)
 ;;=4^V76.47
 ;;^UTILITY(U,$J,358.3,2509,2)
 ;;=^322085
 ;;^UTILITY(U,$J,358.3,2510,0)
 ;;=V76.50^^27^188^77
 ;;^UTILITY(U,$J,358.3,2510,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2510,1,3,0)
 ;;=3^SPC SCRN MALIG NEO,UNS INTESTI
 ;;^UTILITY(U,$J,358.3,2510,1,4,0)
 ;;=4^V76.50
 ;;^UTILITY(U,$J,358.3,2510,2)
 ;;=^322088
 ;;^UTILITY(U,$J,358.3,2511,0)
 ;;=V76.51^^27^188^78
 ;;^UTILITY(U,$J,358.3,2511,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2511,1,3,0)
 ;;=3^SPC SCRN MALIG NEOPLASM,COLON
 ;;^UTILITY(U,$J,358.3,2511,1,4,0)
 ;;=4^V76.51
 ;;^UTILITY(U,$J,358.3,2511,2)
 ;;=^322089
 ;;^UTILITY(U,$J,358.3,2512,0)
 ;;=V76.81^^27^188^76
 ;;^UTILITY(U,$J,358.3,2512,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2512,1,3,0)
 ;;=3^SPC SCRN MALIG NEO,NERV SYS
 ;;^UTILITY(U,$J,358.3,2512,1,4,0)
 ;;=4^V76.81
 ;;^UTILITY(U,$J,358.3,2512,2)
 ;;=^322091
 ;;^UTILITY(U,$J,358.3,2513,0)
 ;;=V77.0^^27^188^51
 ;;^UTILITY(U,$J,358.3,2513,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2513,1,3,0)
 ;;=3^SCREEN-THYROID DISORDER
 ;;^UTILITY(U,$J,358.3,2513,1,4,0)
 ;;=4^V77.0
 ;;^UTILITY(U,$J,358.3,2513,2)
 ;;=^295661
 ;;^UTILITY(U,$J,358.3,2514,0)
 ;;=V77.1^^27^188^36
 ;;^UTILITY(U,$J,358.3,2514,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2514,1,3,0)
 ;;=3^SCREEN-DIABETES MELLITUS
 ;;^UTILITY(U,$J,358.3,2514,1,4,0)
 ;;=4^V77.1
 ;;^UTILITY(U,$J,358.3,2514,2)
 ;;=^295662
 ;;^UTILITY(U,$J,358.3,2515,0)
 ;;=V77.2^^27^188^16
 ;;^UTILITY(U,$J,358.3,2515,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2515,1,3,0)
 ;;=3^SCREEN FOR MALNUTRITION
 ;;^UTILITY(U,$J,358.3,2515,1,4,0)
 ;;=4^V77.2
 ;;^UTILITY(U,$J,358.3,2515,2)
 ;;=^295663
 ;;^UTILITY(U,$J,358.3,2516,0)
 ;;=V77.3^^27^188^44
 ;;^UTILITY(U,$J,358.3,2516,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2516,1,3,0)
 ;;=3^SCREEN-PHENYLKETONURIA
 ;;^UTILITY(U,$J,358.3,2516,1,4,0)
 ;;=4^V77.3
 ;;^UTILITY(U,$J,358.3,2516,2)
 ;;=^295664
 ;;^UTILITY(U,$J,358.3,2517,0)
 ;;=V77.4^^27^188^11
 ;;^UTILITY(U,$J,358.3,2517,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2517,1,3,0)
 ;;=3^SCREEN FOR GALACTOSEMIA
 ;;^UTILITY(U,$J,358.3,2517,1,4,0)
 ;;=4^V77.4
 ;;^UTILITY(U,$J,358.3,2517,2)
 ;;=^295665
 ;;^UTILITY(U,$J,358.3,2518,0)
 ;;=V77.5^^27^188^60
 ;;^UTILITY(U,$J,358.3,2518,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2518,1,3,0)
 ;;=3^SCREENING FOR GOUT
 ;;^UTILITY(U,$J,358.3,2518,1,4,0)
 ;;=4^V77.5
 ;;^UTILITY(U,$J,358.3,2518,2)
 ;;=^295666
 ;;^UTILITY(U,$J,358.3,2519,0)
 ;;=V77.6^^27^188^34
 ;;^UTILITY(U,$J,358.3,2519,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2519,1,3,0)
 ;;=3^SCREEN-CYSTIC FIBROSIS
 ;;^UTILITY(U,$J,358.3,2519,1,4,0)
 ;;=4^V77.6
 ;;^UTILITY(U,$J,358.3,2519,2)
 ;;=^295667
 ;;^UTILITY(U,$J,358.3,2520,0)
 ;;=V77.7^^27^188^38
 ;;^UTILITY(U,$J,358.3,2520,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2520,1,3,0)
 ;;=3^SCREEN-INBORN ERR METAB
 ;;^UTILITY(U,$J,358.3,2520,1,4,0)
 ;;=4^V77.7
 ;;^UTILITY(U,$J,358.3,2520,2)
 ;;=^295668
 ;;^UTILITY(U,$J,358.3,2521,0)
 ;;=V77.8^^27^188^63
 ;;^UTILITY(U,$J,358.3,2521,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2521,1,3,0)
 ;;=3^SCREENING FOR OBESITY
 ;;^UTILITY(U,$J,358.3,2521,1,4,0)
 ;;=4^V77.8
 ;;^UTILITY(U,$J,358.3,2521,2)
 ;;=^295669
 ;;^UTILITY(U,$J,358.3,2522,0)
 ;;=V77.91^^27^188^65
 ;;^UTILITY(U,$J,358.3,2522,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2522,1,3,0)
 ;;=3^SCREENING LIPOID DISORDERS
 ;;^UTILITY(U,$J,358.3,2522,1,4,0)
 ;;=4^V77.91
 ;;^UTILITY(U,$J,358.3,2522,2)
 ;;=^322093
 ;;^UTILITY(U,$J,358.3,2523,0)
 ;;=V78.0^^27^188^39
 ;;^UTILITY(U,$J,358.3,2523,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2523,1,3,0)
 ;;=3^SCREEN-IRON DEFIC ANEMIA
 ;;^UTILITY(U,$J,358.3,2523,1,4,0)
 ;;=4^V78.0
 ;;^UTILITY(U,$J,358.3,2523,2)
 ;;=^295671
 ;;^UTILITY(U,$J,358.3,2524,0)
 ;;=V78.1^^27^188^35
 ;;^UTILITY(U,$J,358.3,2524,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2524,1,3,0)
 ;;=3^SCREEN-DEFIC ANEMIA NEC
 ;;^UTILITY(U,$J,358.3,2524,1,4,0)
 ;;=4^V78.1
 ;;^UTILITY(U,$J,358.3,2524,2)
 ;;=^295672
 ;;^UTILITY(U,$J,358.3,2525,0)
 ;;=V78.2^^27^188^50
 ;;^UTILITY(U,$J,358.3,2525,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2525,1,3,0)
 ;;=3^SCREEN-SICKLE CELL DIS
 ;;^UTILITY(U,$J,358.3,2525,1,4,0)
 ;;=4^V78.2
 ;;^UTILITY(U,$J,358.3,2525,2)
 ;;=^295673
 ;;^UTILITY(U,$J,358.3,2526,0)
 ;;=V78.3^^27^188^69
